Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 42 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Vlachaki, Efthymia [Clear All Filters]
Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia..
Hemasphere. 2(5), e58.
(2018). Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence..
Acta Haematol. 137(3), 175-182.
(2017). Production and Transduction of a Human Recombinant β-Globin Chain into Proerythroid K-562 Cells To Replace Missing Endogenous β-Globin..
Mol Pharm. 15(12), 5665-5677.
(2018). Pure red cell aplasia and lymphoproliferative disorders: an infrequent association..
ScientificWorldJournal. 2012, 475313.
(2012). Relationship between Helicobacter pylori infection and multiple sclerosis..
Ann Gastroenterol. 28(3), 353-356.
(2015). Rivaroxaban Use in Patients with Hemoglobinopathies..
Hemoglobin. 41(3), 223-224.
(2017). The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?.
Turk J Haematol. 33(2), 88-93.
(2016). Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study..
Hemoglobin. 43(1), 27-33.
(2019). Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review..
J Obstet Gynaecol. 38(4), 443-447.
(2018). Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia..
Case Rep Hematol. 2014, 213631.
(2014). Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition..
Hemoglobin. 42(5-6), 339-341.
(2018). Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents..
Balkan Med J. 35(1), 112-115.
(2018). Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?.
Acta Haematol. 133(1), 78-82.
(2015). Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition..
Transfus Apher Sci. 51(2), 175-7.
(2014). A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes..
Surg Innov. 24(6), 543-551.
(2017). Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).